DFFCX
Price
$60.37
Change
+$3.08 (+5.38%)
Updated
Feb 3 closing price
Net Assets
1.21B
SBFAX
Price
$26.37
Change
-$3.42 (-11.48%)
Updated
Feb 3 closing price
Net Assets
105.67M
Interact to see
Advertisement

DFFCX vs SBFAX

Header iconDFFCX vs SBFAX Comparison
Open Charts DFFCX vs SBFAXBanner chart's image
Davis Financial C
Price$60.37
Change+$3.08 (+5.38%)
VolumeN/A
Net Assets1.21B
1919 Financial Services A
Price$26.37
Change-$3.42 (-11.48%)
VolumeN/A
Net Assets105.67M
DFFCX vs SBFAX Comparison Chart in %
View a ticker or compare two or three
VS
DFFCX vs. SBFAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFCX is a Buy and SBFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFCX has more cash in the bank: 1.21B vs. SBFAX (106M). DFFCX pays higher dividends than SBFAX: DFFCX (0.59) vs SBFAX (0.07). DFFCX was incepted earlier than SBFAX: DFFCX (29 years) vs SBFAX (27 years). DFFCX (1.74) is less costly to investors than SBFAX (1.46). SBFAX is a more actively managed with annual turnover of: 4.00 vs. DFFCX (2.00). DFFCX (1000) and SBFAX (1000) have matching initial minimum investment requirements. DFFCX annual gain was more profitable for investors over the last year : 18.21 vs. SBFAX (-12.42). DFFCX return over 5 years is better than : 70.42 vs. SBFAX (-6.16).
DFFCXSBFAXDFFCX / SBFAX
Total Expense Ratio1.741.46119%
Annual Report Gross Expense Ratio1.741.46119%
Fund Existence29 years27 years-
Gain YTD0.199-0.265-75%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B106M1,139%
Annual Yield % from dividends0.590.07838%
Returns for 1 year18.21-12.42-147%
Returns for 3 years50.65-10.09-502%
Returns for 5 years70.42-6.16-1,143%
Returns for 10 years113.2859.53190%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLO27.410.62
+2.31%
Ames National Corp
PHAR17.260.28
+1.68%
Pharming Group NV
REZI35.970.57
+1.61%
Resideo Technologies
REGN759.184.16
+0.55%
Regeneron Pharmaceuticals
ZGM2.20-0.01
-0.45%
Zenta Group Company Limited